LQDA(Liquidia Corporation) · 财务报表

LQDA(Liquidia Corporation) 的财务报表:医疗保健,特药与仿制药。数据来自 SEC 公开申报与市场行情,不构成投资建议。

近年年度财务(SEC XBRL)
科目FY 截至 2021-12-31FY 截至 2022-12-31FY 截至 2023-12-31FY 截至 2024-12-31FY 截至 2025-12-31
营业收入$12.85M$15.94M$17.49M$14.00M$158.32M
毛利润$9.83M$13.08M$14.60M$8.12M—
营业利润−$33.80M−$38.77M−$73.38M−$121.29M−$51.38M
净利润−$34.58M−$41.02M−$78.50M−$128.29M−$68.92M
经营现金流−$34.03M−$28.59M−$41.56M−$93.42M−$35.69M
自由现金流−$34.14M−$29.18M−$42.85M−$98.37M−$40.02M
摊薄每股收益$-0.70$-0.67$-1.21$-1.63$-0.80

Liquidia Corporation LQDA